Ryan Spangler

Ryan has over 5+ years of research experience in drug development and diagnostics from the NIH and Broad Institute of MIT and Harvard. He is a coauthor on 7 different peer reviewed papers in journals such as Nature Cancer and JAMA Neurology. At the Broad, he currently is a Research Associate developing systematic ways to repurpose existing small molecules for new disease indications. Ryan has been instrumental in Cogentis’s fundraising, business development, and scientific direction.